SKYE

0.700011.03%
PA

Paul A. Grayson

Independent Chairman of the Board

Mr. Paul A. Grayson, M.B.A. is Chief Executive Officer of Radionetics Oncology, Inc. from January 2024 and also serves as its Director. He was the President, CEO and Director of Tentarix Biotherapeutics Inc since July 2020 until November 2023. He has been an Independent Director at Skye Bioscience, Inc. since August 2023 and also serves as its Independent Chairman of the Board since October 25, 2024. He was a Venture Partner at Versant Venture Management, LLC since 2020 and was its Partner from June 2018 to 2020. He joined the firm in 2018. He is a part of the investment team. He was the Chief Executive Officer and President of Bird Rock Bio, Inc. since June 23, 2011 and served as its Director. He serves as Director of Pipeline Therapeutics, Inc. since November 2018. He was Director at Tempest Therapeutics Inc. until June 28, 2021. He is a Director of Taligen Therapeutics, Zapaq and Chimerix. He serves as a Director of Anaphore, Inc. Mr. Grayson served as Chief Executive Officer at Fate Therapeutics, Inc. until February 2011. Mr. Grayson's background includes a stint as Managing Director at Sanderling Ventures. Earlier, he served as the Chairman, Chief Executive Officer, President and Director of Senomyx, Inc. which he founded. Mr. Grayson was a Founding Member of the management team at Aurora Biosciences Corporation and became a Senior Vice President of Corporate Development. From November 1987 to April 1996, he held various discovery research, marketing, finance and business development positions at Allergan, Inc.; Gensia Inc.; and Advanced Tissue Sciences, Inc. He served as a Director of DiscoveRx Corporation. He served as a Director of CalciMedica and Receptos, Inc. Previously, he was employed at Alpine Capital Partners, L.L.C. Mr. Grayson served as a Director of Ambit Biosciences. Mr. Grayson received an M.B.A. from the University of California, Irvine in 1989 and a B.A. in Computer Science and Biochemistry from the University of California in Los Angeles in 1986.

Positions